Amdocs (NASDAQ:DOX) Releases Quarterly Earnings Results, Misses Expectations By $0.12 EPS
by Amy Steele · The Cerbat GemAmdocs (NASDAQ:DOX – Get Free Report) announced its quarterly earnings results on Tuesday. The technology company reported $1.63 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.75 by ($0.12), Zacks reports. Amdocs had a return on equity of 19.78% and a net margin of 12.46%.
Amdocs Trading Down 8.6%
Shares of DOX stock traded down $6.99 on Tuesday, hitting $74.02. 3,187,177 shares of the company’s stock traded hands, compared to its average volume of 1,049,567. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.17 and a current ratio of 1.17. Amdocs has a one year low of $73.18 and a one year high of $95.41. The company’s fifty day simple moving average is $80.42 and its 200 day simple moving average is $82.74. The stock has a market capitalization of $7.99 billion, a price-to-earnings ratio of 14.66, a P/E/G ratio of 1.39 and a beta of 0.40.
Amdocs Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Friday, January 30th. Stockholders of record on Wednesday, December 31st were paid a $0.527 dividend. The ex-dividend date of this dividend was Wednesday, December 31st. This represents a $2.11 dividend on an annualized basis and a dividend yield of 2.8%. Amdocs’s dividend payout ratio is 41.78%.
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently modified their holdings of the stock. WealthCollab LLC lifted its stake in shares of Amdocs by 94.5% in the 3rd quarter. WealthCollab LLC now owns 356 shares of the technology company’s stock valued at $29,000 after acquiring an additional 173 shares during the last quarter. Advisory Services Network LLC bought a new position in Amdocs during the 3rd quarter worth approximately $42,000. CIBC Private Wealth Group LLC increased its stake in Amdocs by 190.2% in the 3rd quarter. CIBC Private Wealth Group LLC now owns 595 shares of the technology company’s stock worth $49,000 after purchasing an additional 390 shares during the period. Geneos Wealth Management Inc. lifted its position in Amdocs by 213.9% in the first quarter. Geneos Wealth Management Inc. now owns 700 shares of the technology company’s stock valued at $64,000 after purchasing an additional 477 shares during the last quarter. Finally, Caitong International Asset Management Co. Ltd boosted its stake in shares of Amdocs by 68.4% during the third quarter. Caitong International Asset Management Co. Ltd now owns 795 shares of the technology company’s stock valued at $65,000 after purchasing an additional 323 shares during the period. 92.02% of the stock is owned by institutional investors.
Wall Street Analyst Weigh In
Several research analysts have commented on DOX shares. Bank of America cut their price target on shares of Amdocs from $100.00 to $97.00 and set a “buy” rating for the company in a report on Wednesday, November 12th. Weiss Ratings reissued a “hold (c)” rating on shares of Amdocs in a research note on Tuesday, January 27th. Wall Street Zen lowered Amdocs from a “buy” rating to a “hold” rating in a research note on Saturday, January 3rd. Wolfe Research reiterated a “peer perform” rating on shares of Amdocs in a research report on Thursday, November 13th. Finally, Stifel Nicolaus cut their price objective on Amdocs from $100.00 to $97.00 and set a “buy” rating for the company in a report on Wednesday, November 12th. Two analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat, Amdocs presently has an average rating of “Moderate Buy” and a consensus target price of $97.00.
Get Our Latest Report on Amdocs
Amdocs Company Profile
Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.
Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.
Read More
- Five stocks we like better than Amdocs
- The day the gold market broke
- Forget AI, This Will Be the Next Big Tech Breakthrough
- Ticker Revealed: Pre-IPO Access to “Next Elon Musk” Company
- ALERT: Drop these 5 stocks before the market opens tomorrow!
- Trump Planning to Use Public Law 63-43: Prepare Now